Wai Yuen Tong Medicine Holdings Limited (HKG:0897)
0.3600
+0.0100 (2.86%)
Apr 24, 2025, 3:28 PM HKT
HKG:0897 Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Net Income | 4.8 | -15.36 | -20.52 | -108.91 | -376 | 438.55 | Upgrade
|
Depreciation & Amortization | 112.28 | 111.15 | 113.05 | 107.8 | 92.62 | 112.67 | Upgrade
|
Loss (Gain) From Sale of Assets | -18.2 | -18.2 | 7.5 | -1.81 | 6.56 | -60.83 | Upgrade
|
Asset Writedown & Restructuring Costs | 153.98 | 153.98 | 24.78 | 80.62 | 56.95 | 181.67 | Upgrade
|
Loss (Gain) From Sale of Investments | 13.98 | 13.98 | 22.12 | 86.03 | 272.24 | -68.01 | Upgrade
|
Loss (Gain) on Equity Investments | -2.53 | -2.53 | -2.95 | -1.57 | -4.65 | -15.18 | Upgrade
|
Stock-Based Compensation | 3.84 | 3.84 | 4.65 | 1.14 | - | - | Upgrade
|
Other Operating Activities | -86.62 | -31.51 | 61.49 | 65.5 | 65.13 | -573.99 | Upgrade
|
Change in Accounts Receivable | -13.14 | -13.14 | -14 | -14.43 | 16.49 | 19.88 | Upgrade
|
Change in Inventory | -45.96 | -45.96 | 94.91 | 303.02 | 126.07 | -15.48 | Upgrade
|
Change in Accounts Payable | -2.29 | -2.29 | -3.14 | 12.21 | 1.68 | -17.18 | Upgrade
|
Change in Unearned Revenue | -0.79 | -0.79 | -49 | -372.94 | 2.52 | 24.92 | Upgrade
|
Change in Other Net Operating Assets | -24.8 | -24.8 | -64.51 | 12.45 | 152.93 | -59.56 | Upgrade
|
Operating Cash Flow | 157.86 | 191.69 | 168.34 | 169.11 | 412.55 | -32.52 | Upgrade
|
Operating Cash Flow Growth | -21.75% | 13.87% | -0.46% | -59.01% | - | - | Upgrade
|
Capital Expenditures | -4.49 | -34.65 | -33.45 | -26.04 | -59.5 | -6.81 | Upgrade
|
Sale of Property, Plant & Equipment | 83.6 | 86.82 | 2.6 | 0.88 | 4.25 | 142.95 | Upgrade
|
Cash Acquisitions | -78.12 | -78.12 | - | - | - | -118.5 | Upgrade
|
Divestitures | -140.05 | -72.72 | 46.65 | - | - | 148.72 | Upgrade
|
Investment in Securities | 90.34 | 69.26 | -3.38 | 20.23 | 8.14 | 156.53 | Upgrade
|
Other Investing Activities | 65.96 | 54.4 | 1.3 | 22.37 | 17.3 | 87.58 | Upgrade
|
Investing Cash Flow | 69.88 | -84.62 | 19.25 | 6.47 | -64.49 | 425.24 | Upgrade
|
Long-Term Debt Issued | - | 818.97 | 952.2 | 589.87 | 426.36 | 590.78 | Upgrade
|
Long-Term Debt Repaid | - | -1,117 | -1,004 | -679.51 | -692.85 | -627.28 | Upgrade
|
Net Debt Issued (Repaid) | -311.21 | -297.69 | -51.99 | -89.64 | -266.48 | -36.5 | Upgrade
|
Repurchase of Common Stock | -11.8 | -14.73 | -9.96 | - | - | - | Upgrade
|
Common Dividends Paid | -198.84 | - | - | - | - | - | Upgrade
|
Other Financing Activities | -93.36 | -157.55 | -96.96 | -114.78 | -84.39 | -45.13 | Upgrade
|
Financing Cash Flow | -615.21 | -469.97 | -158.91 | -204.41 | -350.88 | -81.62 | Upgrade
|
Foreign Exchange Rate Adjustments | 26.91 | -8.83 | -12.12 | 31.75 | 34.35 | -6.6 | Upgrade
|
Net Cash Flow | -360.56 | -371.73 | 16.56 | 2.91 | 31.53 | 304.49 | Upgrade
|
Free Cash Flow | 153.37 | 157.04 | 134.89 | 143.07 | 353.05 | -39.33 | Upgrade
|
Free Cash Flow Growth | -1.28% | 16.42% | -5.72% | -59.48% | - | - | Upgrade
|
Free Cash Flow Margin | 20.12% | 20.03% | 18.64% | 10.28% | 31.85% | -6.34% | Upgrade
|
Free Cash Flow Per Share | 0.13 | 0.13 | 0.11 | 0.12 | 0.29 | -0.03 | Upgrade
|
Cash Interest Paid | 107.09 | 139.82 | 86.35 | 58.46 | 84.39 | 45.13 | Upgrade
|
Cash Income Tax Paid | 15.39 | 34.64 | 53.06 | 81.87 | 89.87 | 13.24 | Upgrade
|
Levered Free Cash Flow | 915.66 | 733.16 | -5.57 | 22.41 | 313.76 | -1,077 | Upgrade
|
Unlevered Free Cash Flow | 937.89 | 758.65 | 12.87 | 82.22 | 381.08 | -1,044 | Upgrade
|
Change in Net Working Capital | -822.37 | -652.76 | 74.5 | 44.17 | -339.32 | 1,067 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.